业绩与股价 “冰火两重天”！潍坊上市公司亚星化学2025年预亏超1.4亿，股价却翻倍

Core Viewpoint - The financial performance of Yaxing Chemical for 2024 shows significant losses, with a net profit attributable to shareholders of approximately -97.03 million yuan, primarily due to intensified market competition and low product prices [1] Group 1: Financial Performance - In 2024, Yaxing Chemical reported a total profit of -98.32 million yuan and a net profit attributable to shareholders of -97.03 million yuan, with a net profit excluding non-recurring gains and losses of about -156 million yuan [1] - The company received compensation of 46.74 million yuan for losses related to relocation, which will positively impact the net profit and net assets attributable to shareholders for 2025 [1] Group 2: Operational Insights - The company has seen steady progress in production and operations, with a continuous growth trend in the production and sales of its main products since the relocation [1] - Despite the ongoing development of new projects, including a 45,000-ton high-end new material (PVDC) project and other industrialization projects, these have not yet impacted the 2025 performance, which will still rely on existing product lines [1] Group 3: Strategic Developments - Yaxing Chemical has undergone significant ownership changes, with Shenzhen Changcheng Huili becoming the controlling shareholder in 2016, followed by a restructuring in 2022 that led to the Weifang City Investment Group acquiring control [4] - The company initiated a new PVDC material project in collaboration with South Korea's SK Group, which is expected to be operational by 2025 [4] - In 2026, Yaxing Chemical announced the termination of a major asset restructuring plan to acquire Shandong Tianyi Chemical, indicating a shift in strategic focus [4] Group 4: Market Performance - Despite the financial struggles, Yaxing Chemical's stock price saw a remarkable increase of 93.3% in 2025, contrasting sharply with the company's ongoing losses [4] - For the first three quarters of 2025, the company reported a net profit loss of 144 million yuan, highlighting the disparity between market performance and financial health [4]